Author:
Wikström I,Lindell M,Sanner K,Wilander E
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg S (2008) Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 100: 605–606
2. Bos A, Rebolj M, Habbema JD, van Ballegooijen M (2006) Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands. Int J Cancer 119: 2372–2375
3. Eaker S, Adami HO, Granath F, Wilander E, Sparén P (2004) A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. Cancer Epidemiol Biomarkers Prev 13: 346–354
4. Gustafsson L, Sparén P, Gustafsson M, Pettersson B, Wilander E, Bergstrom R, Adami HO (1995) Low efficiency of cytological screening for cancer in situ of the cervix in older women. Int J Cancer 63: 804–809
5. Gyllensten U, Lindell M, Gustafsson I, Wilander E (2010) HPV test shows low sensitivity of Pap screen in older women. Lancet Oncol 11: 509–510
Cited by
100 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献